Friday 6 November 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.

Revenue: +8.69%
EPS: +56.7%
Free cash flow: +12.3%
Total debt: +0.10%

Quarter to September 2026, against a year earlier

392.97 15.81 −3.87%

Follow WST

Alert me

Market cap: $27.3B
P/E: 43.8×
Fwd P/E: 48.1×
Dividend yield: 0.22%
F-score: 8/9
Altman Z: 13.89
Beneish M: −2.79
Dividend safety: 100/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	8	8	9	8
ROE Full definition →		16.85%	19.13%	19.09%	21.23%
ROA Full definition →		12.48%	14.05%	14.07%	15.65%
ROIC Full definition →		14.13%	15.32%	15.42%	18.01%
Return on Tangible Assets Full definition →		16.19%	19.01%	19.80%	22.46%
Average Days of Receivables Full definition →		68.20	77.69	78.12	80.40
Free Cash Flow per Share Full definition →		6.49	6.36	6.17	6.44
Free Cash Flow Full definition →		468.90	458.00	436.90	453.40
Capital Expenditures Full definition →		(285.90)	(257.30)	(225.30)	(201.10)
Other line items
Cash ROIC Full definition →		11.24%	12.33%	12.04%	12.47%
Accounts Receivable Turnover Full definition →		5.46	5.24	5.14	4.95
Accounts Payable Turnover Full definition →		7.99	8.54	8.55	8.39
Inventory Turnover Full definition →		4.80	4.88	4.84	4.70
Average Days of Payables Full definition →		47.00	44.87	43.86	42.94
Days of Inventory on Hand Full definition →		82.24	80.49	77.65	80.01
Tax Rate Full definition →		(0.20)	(0.21)	(0.21)	(0.21)
Research and Development Expense of Revenue Full definition →		2.42%	2.29%	2.24%	2.23%
Selling, General and Administrative Expense of Revenue Full definition →		12.80%	12.58%	12.83%	12.87%
Share Based Compensation of Revenue Full definition →		0.77%	0.90%	0.98%	0.84%
Interest Coverage Full definition →		1,169.80	327.50	151.20	96.32
Operating CF/Net income Full definition →		1.53	1.32	1.17	1.02
Depreciation/Fixed assets Full definition →		0.10	0.10	0.11	0.11
Capex/Depreciation Full definition →		(1.67)	(1.46)	(1.24)	(1.09)
Revenue per Share Full definition →		42.52	44.74	46.99	48.25
Operating CF per Share Full definition →		10.44	9.93	9.35	9.30
Capex per Share Full definition →		(3.95)	(3.57)	(3.18)	(2.86)
Capex to Sales Full definition →		0.09	0.08	0.07	0.06

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly